IRIS Accounts Production v25.4.0.155 11772572 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary 0.01000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 11772572 2024-03-31 11772572 2025-03-31 11772572 2024-04-01 2025-03-31 11772572 2023-03-31 11772572 2023-04-01 2024-03-31 11772572 2024-03-31 11772572 ns15:EnglandWales 2024-04-01 2025-03-31 11772572 ns14:PoundSterling 2024-04-01 2025-03-31 11772572 ns10:Director1 2024-04-01 2025-03-31 11772572 ns10:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11772572 ns10:SmallEntities 2024-04-01 2025-03-31 11772572 ns10:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 11772572 ns10:SmallCompaniesRegimeForDirectorsReport 2024-04-01 2025-03-31 11772572 ns10:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11772572 ns10:FullAccounts 2024-04-01 2025-03-31 11772572 ns10:OrdinaryShareClass1 2024-04-01 2025-03-31 11772572 1 2024-04-01 2025-03-31 11772572 ns10:Director2 2024-04-01 2025-03-31 11772572 ns10:Director3 2024-04-01 2025-03-31 11772572 ns10:RegisteredOffice 2024-04-01 2025-03-31 11772572 ns5:CurrentFinancialInstruments 2025-03-31 11772572 ns5:CurrentFinancialInstruments 2024-03-31 11772572 ns5:ShareCapital 2025-03-31 11772572 ns5:ShareCapital 2024-03-31 11772572 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 11772572 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 11772572 ns5:FurnitureFittings 2024-04-01 2025-03-31 11772572 ns5:ComputerEquipment 2024-04-01 2025-03-31 11772572 ns5:FurnitureFittings 2024-03-31 11772572 ns5:ComputerEquipment 2024-03-31 11772572 ns5:FurnitureFittings 2025-03-31 11772572 ns5:ComputerEquipment 2025-03-31 11772572 ns5:FurnitureFittings 2024-03-31 11772572 ns5:ComputerEquipment 2024-03-31 11772572 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31 11772572 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-03-31 11772572 ns10:OrdinaryShareClass1 2025-03-31

REGISTERED NUMBER: 11772572 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

CLINICAL METRICS LTD

PREVIOUSLY KNOWN AS

YELLOW BIRD CONSULTING LTD

| CLINICAL METRICS LTD (REGISTERED NUMBER: 11772572) |

Contents of the Financial Statements

for the year ended 31 March 2025

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| CLINICAL METRICS LTD |

Company Information

for the year ended 31 March 2025

| Directors: | T Raupach

| C Morton

| M Flitton

| Registered office: | Building 423 - Sky View (Ro)

| Argosy Road

| East Midlands Airport

| Derby

| DE74 2SA

| Registered number: | 11772572 (England and Wales)

| Accountants: | Cooper Parry Advisory Limited

| Broadwalk House, 5th Floor

| 5 Appold Street

| Broadgate

| London

| EC2A 2AG

| CLINICAL METRICS LTD (REGISTERED NUMBER: 11772572) |

Balance Sheet

31 March 2025

2025 | 2024 |

| Notes | £ | £ | £ | £

Fixed assets

Tangible assets | 4 | 6,482 |  | 9,262 |  |

Current assets

Debtors | 5 | 38,192 |  | 7,820 |  |

Cash at bank | 31,804 |  | 85,467 |  |

69,996 |  | 93,287 |  |

Creditors

Amounts falling due within one year | 6 | 11,411 |  | 14,680 |  |

Net current assets | 58,585 |  | 78,607 |  |

Total assets less current liabilities | 65,067 |  | 87,869 |  |

Provisions for liabilities | 1,232 |  | - |  |

Net assets | 63,835 |  | 87,869 |  |

Capital and reserves

Called up share capital | 7 | 3,000 |  | 3,000 |  |

Retained earnings | 60,835 |  | 84,869 |  |

Shareholders' funds | 63,835 |  | 87,869 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 December 2025 and were signed on its behalf by:

C Morton - Director

| CLINICAL METRICS LTD (REGISTERED NUMBER: 11772572) |

Notes to the Financial Statements

for the year ended 31 March 2025

1. | Statutory information

| Clinical Metrics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | Accounting policies

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Fixtures and fittings | - | 15% on reducing balance

| Computer equipment | - | 33% on cost and 25% on cost

| Financial instruments

| Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

| Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

| Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

| Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| CLINICAL METRICS LTD (REGISTERED NUMBER: 11772572) |

Notes to the Financial Statements - continued

for the year ended 31 March 2025

2. | Accounting policies - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | Employees and directors

| The average number of employees during the year was 1 (2024 - 3 ) .

4. | Tangible fixed assets

Fixtures |

and | Computer |

fittings | equipment | Totals |

| £ | £ | £

| Cost

| At 1 April 2024 | 237 |  | 15,346 |  | 15,583 |  |

| Additions | - |  | 3,190 |  | 3,190 |  |

| Disposals | - |  | (1,124 | ) | (1,124 | ) |

| At 31 March 2025 | 237 |  | 17,412 |  | 17,649 |  |

| Depreciation

| At 1 April 2024 | 114 |  | 6,207 |  | 6,321 |  |

| Charge for year | 19 |  | 5,264 |  | 5,283 |  |

| Eliminated on disposal | - |  | (437 | ) | (437 | ) |

| At 31 March 2025 | 133 |  | 11,034 |  | 11,167 |  |

| Net book value

| At 31 March 2025 | 104 |  | 6,378 |  | 6,482 |  |

| At 31 March 2024 | 123 |  | 9,139 |  | 9,262 |  |

5. | Debtors: amounts falling due within one year |

2025 | 2024 |

| £ | £

| Trade debtors | 28,153 |  | - |  |

| Other debtors | 10,039 |  | 7,820 |  |

38,192 |  | 7,820 |  |

| CLINICAL METRICS LTD (REGISTERED NUMBER: 11772572) |

Notes to the Financial Statements - continued

for the year ended 31 March 2025

6. | Creditors: amounts falling due within one year |

2025 | 2024 |

| £ | £

| Trade creditors | 11,389 |  | 861 |  |

| Taxation and social security | - |  | 13,797 |  |

| Other creditors | 22 |  | 22 |  |

11,411 |  | 14,680 |  |

7. | Called up share capital

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2025 | 2024 |

value: |  | £ | £

| 300,000 | Ordinary | 0.01 | 3,000 |  | 3,000 |  |

8. | Related party disclosures

| At the year end there were amounts owed by directors of the company of £978 (2024: £978). These amounts are unsecured, interest free and repayable on demand.